Cancer Causes & Control

, 22:1563 | Cite as

Uranium carcinogenicity in humans might depend on the physical and chemical nature of uranium and its isotopic composition: results from pilot epidemiological study of French nuclear workers

  • I. Guseva Canu
  • S. Jacob
  • E. Cardis
  • P. Wild
  • S. Caër
  • B. Auriol
  • J. P. Garsi
  • M. Tirmarche
  • D. Laurier
Original paper
First Online:
Received:
Accepted:

Abstract

Objective

To study the cancer risk related to protracted, low-dose exposure to different industrial uranium compounds, paying attention to their isotopic composition and solubility.

Methods

Two thousand and ninety-seven workers employed at the AREVA NC uranium processing plant (France) were followed up for mortality from 1960 to 2006. Historical exposure to uranium and other carcinogenic chemical and physical pollutants was assessed on the basis of the plant-specific job-exposure matrix. For each type of uranium, Cox regression models stratified on sex and calendar period, and adjusted for socioeconomic status and potentially confounding co-exposures were used to estimate hazard ratios (HRs) for mortality from lung cancer (53 deaths) and lymphatic and hematopoietic tissue malignancies (21 deaths).

Results

We observed that exposure to reprocessed uranium entails increasing risks of mortality from lung cancer and lymphatic and hematopoietic malignancies (the most significant HR being respectively 1.14 (95% CI: 1.00–1.31) and 1.20 (95% CI: 1.01–1.43) per unit of a time-lagged log-transformed continuous exposure scores), and that the HRs tend to increase with decreasing solubility of the compounds.

Conclusion

Our results suggest that uranium carcinogenicity may depend on isotopic composition and solubility of uranium compounds. This study is the first to show the carcinogenic effect of slowly soluble reprocessed uranium on two uranium target organs. This finding is consistent with data from epidemiological and experimental studies on similar compounds but need to be confirmed in the more powerful dose–response analysis.

Keywords

Epidemiology Mortality Uranium Plutonium Cancer 
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

The authors would like to thank the Chief Medical Officer of the AREVA group, Dr. Acker, as well as all people from the AREVA NC Pierrelatte plant who took part in this study. We gratefully acknowledge Dr. Blanchardon and Dr. Paquet from the IRSN for helping us to understand the biological mechanism of reprocessed uranium compounds. We also thank our colleague, Mr. Samson, from the IRSN and our colleagues from the “Alpha risk” project network for their advice and their review of this paper. This work was funded by the IRSN and AREVA (PIC-Epidemiology 2006/2009 grant), with partial financial support from the EC (EURATOM FIP6-516483 grant).

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

10552_2011_9833_MOESM1_ESM.doc (35 kb)
Supplementary material 1 (DOC 35 kb)
10552_2011_9833_MOESM2_ESM.doc (36 kb)
Supplementary material 2 (DOC 36 kb)
10552_2011_9833_MOESM3_ESM.doc (34 kb)
Supplementary material 3 (DOC 33 kb)

References

  1. 1.
    United Nations Scientific Committee on the Effects of Atomic Radiation (2000) Report to the General Assembly Unscear. United NationsGoogle Scholar
  2. 2.
    IARC (2001) Ionizing radiation, part 2: some internally deposited radionuclides. Int Agency Res Cancer Monogr Eval Carcinog Risks Hum 78:1–559Google Scholar
  3. 3.
    Auvinen A, Kurttio P, Pekkanen J, Pukkala E, Ilus T, Salonen L (2002) Uranium and other natural radionuclides in drinking water and risk of leukemia: a case-cohort study in Finland. Cancer Causes Control 13:825–829PubMedCrossRefGoogle Scholar
  4. 4.
    Kurttio P, Komulainen H, Leino A, Salonen L, Auvinen A, Saha H (2005) Bone as a possible target of chemical toxicity of natural uranium in drinking water. Environ Health Perspect 113:68–72PubMedCrossRefGoogle Scholar
  5. 5.
    Kurttio P, Salonen L, Ilus T, Pekkanen J, Pukkala E, Auvinen A (2006) Well water radioactivity and risk of cancers of the urinary organs. Environ Res 102:333–338PubMedCrossRefGoogle Scholar
  6. 6.
    Guseva Canu I, Ellis ED, Tirmarche M (2008) Cancer risk in nuclear workers occupationally exposed to uranium-emphasis on internal exposure. Health Phys 94:1–17CrossRefGoogle Scholar
  7. 7.
    United Nations Scientific Committee on the Effects of Atomic Radiation (2006) Report to the General Assembly Unscear.United NationsGoogle Scholar
  8. 8.
    Bramman JI, Sharpe RM, Thom D, Yates G (1968) Metallic fission-product inclusions in irradiated oxide fuels. J Nucl Mater 25:201–215CrossRefGoogle Scholar
  9. 9.
    Guseva Canu I, Cardis E, Metz-Flamant C et al (2010) French cohort of the uranium processing workers: mortality pattern after 30-year follow-up. Int Arch Occup Environ Health 83:301–308Google Scholar
  10. 10.
    Guseva Canu I, Jacob S, Cardis E et al (2010) Reprocessed uranium exposure and lung cancer risk. Health Phys 99:308–313CrossRefGoogle Scholar
  11. 11.
    Guseva Canu I, Molina G, Goldberg M et al (2008) Development of a job exposure matrix for the epidemiological follow-up of workers in the French nuclear industry. Rev Epidemiol Sante Publique 56:21–29PubMedCrossRefGoogle Scholar
  12. 12.
    Guseva Canu I, Paquet F, Goldberg M et al (2009) Comparative assessing for radiological, chemical, and physical exposures at the French uranium conversion plant: is uranium the only stressor? Int J Hyg Environ Health 212:398–413PubMedCrossRefGoogle Scholar
  13. 13.
    Publication 66 (1994) Human respiratory tract model for radiological protection. Pergamon Press, OxfordGoogle Scholar
  14. 14.
    Chazel V, Houpert P, Ansoborlo E, Henge-Napoli MH, Paquet F (2000) Variation of solubility, biokinetics and dose coefficient of industrial uranium oxides according to specific surface area. Radiat Prot Dosim 88:223–231Google Scholar
  15. 15.
    Chazel V, Houpert P, Paquet F, Ansoborlo E (2001) Effect of absorption parameters on calculation of the dose coefficient: example of classification of industrial uranium compounds. Radiat Prot Dosim 94:261–268Google Scholar
  16. 16.
    Guseva Canu I, Laurier D, Caër-Lorho S et al (2010) Characterisation of protracted low-level exposure to uranium in the workplace: a comparison of two approaches. Int J Hyg Environ Health 213:270–277PubMedCrossRefGoogle Scholar
  17. 17.
    Birchall A, Jarvis NS, Peace MS, Riddell AE, Battersby WP (1998) The IMBA suite: integrated modules for bioassay analysis. Radiat Prot Dosim 79:107–110Google Scholar
  18. 18.
    General guidelines for the assessment of internal dose from monitoring data (project IDEAS—EU contract no FIKR-CT2001-00160). Research Center, Karlsruhe 2006Google Scholar
  19. 19.
    Galle P, Berry JP, Galle C (1992) Role of alveolar macrophages in precipitation of mineral elements inhaled as soluble aerosols. Environ Health Perspect 97:145–147PubMedCrossRefGoogle Scholar
  20. 20.
    Stober W, Morrow PE, Hoover MD (1989) Compartmental modeling of the long-term retention of insoluble particles deposited in the alveolar region of the lung. Fundam Appl Toxicol 13:823–842PubMedCrossRefGoogle Scholar
  21. 21.
    Stober W, Morrow PE, Morawietz G (1990) Alveolar retention and clearance of insoluble particles in rats simulated by a new physiology-oriented compartmental kinetics model. Fundam Appl Toxicol 15:329–349PubMedCrossRefGoogle Scholar
  22. 22.
    Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80PubMedGoogle Scholar
  23. 23.
    Walsh L (2007) A short review of model selection techniques for radiation epidemiology. Radiat Environ Biophys 46:205–213PubMedCrossRefGoogle Scholar
  24. 24.
    Harley NH, Foulkes EC, Hilborne LH, Hudson A, Anthony CR (1999) A review of the scientific literature as it pertains to Gulf war illness. RAND’s National Defense Research Institute, Santa Monica, CA Google Scholar
  25. 25.
    Gilbert ES, Koshurnikova NA, Sokolnikov ME et al (2004) Lung cancer in Mayak workers. Radiat Res 162:505–516PubMedCrossRefGoogle Scholar
  26. 26.
    Koshurnikova NA, Bolotnikova MG, Ilyin LA et al (1998) Lung cancer risk due to exposure to incorporated plutonium. Radiat Res 149:366–371PubMedCrossRefGoogle Scholar
  27. 27.
    Kreisheimer M, Sokolnikov ME, Koshurnikova NA et al (2003) Lung cancer mortality among nuclear workers of the Mayak facilities in the former Soviet Union. An updated analysis considering smoking as the main confounding factor. Radiat Environ Biophys 42:129–135PubMedCrossRefGoogle Scholar
  28. 28.
    Sokolnikov ME, Gilbert ES, Preston DL et al (2008) Lung, liver and bone cancer mortality in Mayak workers. Int J Cancer 123:905–911PubMedCrossRefGoogle Scholar
  29. 29.
    Jacob V, Jacob P, Meckbach R, Romanov SA, Vasilenko EK (2005) Lung cancer in Mayak workers: interaction of smoking and plutonium exposure. Radiat Environ Biophys 44:119–129PubMedCrossRefGoogle Scholar
  30. 30.
    Tokarskaya ZB, Scott BR, Zhuntova GV et al (2002) Interaction of radiation and smoking in lung cancer induction among workers at the Mayak nuclear enterprise. Health Phys 83:833–846PubMedCrossRefGoogle Scholar
  31. 31.
    Omar RZ, Barber JA, Smith PG (1999) Cancer mortality and morbidity among plutonium workers at the Sellafield plant of British Nuclear Fuels. Br J Cancer 79:1288–1301PubMedCrossRefGoogle Scholar
  32. 32.
    Wiggs LD, Johnson ER, Cox-DeVore CA, Voelz GL (1994) Mortality through 1990 among white male workers at the Los Alamos National Laboratory: considering exposures to plutonium and external ionizing radiation. Health Phys 67:577–588PubMedCrossRefGoogle Scholar
  33. 33.
    Brown SC, Schonbeck MF, McClure D et al (2004) Lung cancer and internal lung doses among plutonium workers at the Rocky Flats Plant: a case–control study. Am J Epidemiol 160:163–172PubMedCrossRefGoogle Scholar
  34. 34.
    Wing S, Richardson D, Wolf S, Mihlan G (2004) Plutonium-related work and cause-specific mortality at the United States Department of Energy Hanford Site. Am J Ind Med 45:153–164PubMedCrossRefGoogle Scholar
  35. 35.
    Shilnikova NS, Preston DL, Ron E et al (2003) Cancer mortality risk among workers at the Mayak nuclear complex. Radiat Res 159:787–798PubMedCrossRefGoogle Scholar
  36. 36.
    Atkinson WD, Law DV, Bromley KJ, Inskip HM (2004) Mortality of employess of the United Kingdom atomic energy authority, 1946–1997. Occup Environ Med 61:577–585PubMedCrossRefGoogle Scholar
  37. 37.
    Baysson H, Laurier D, Tirmarche M, Valenty M, Giraud JM (2000) Epidemiological response to a suspected excess of cancer among a group of workers exposed to multiple radiological and chemical hazards. Occup Environ Med 57:188–194PubMedCrossRefGoogle Scholar
  38. 38.
    Boice JD, Cohen SS, Mumma MT et al (2006) Mortality among radiation workers at Rocketdyne (Atomic International), 1948–1999. Radiat Res 165:98–115CrossRefGoogle Scholar
  39. 39.
    Checkoway H, Pearce N, Crawford-Brown DJ, Cragle DL (1988) Radiation doses and cause-specific mortality among workers at a nuclear materials fabrication plant. Am J Epidemiol 127:255–266PubMedGoogle Scholar
  40. 40.
    Cragle DL, McLain RW, Qualters JR et al (1988) Mortality among workers at a nuclear fuels production facility. Am J Ind Med 14:379–401PubMedCrossRefGoogle Scholar
  41. 41.
    Loomis DP, Wolf SH (1996) Mortality of workers at a nuclear materials production plant at Oak Ridge, Tennessee, 1947–1990. Am J Ind Med 29:131–141PubMedCrossRefGoogle Scholar
  42. 42.
    Lopez-Abente G, Aragones N, Pollan M, Ruiz M, Gandarillas A (1999) Leukemia, lymphomas, and myeloma mortality in the vicinity of nuclear power plants and nuclear fuel facilities in Spain. Cancer Epidemiol Biomark Prev 8:925–934Google Scholar
  43. 43.
    Pinkerton LE, Bloom TF, Hein MJ, Ward EM (2004) Mortality among a cohort of uranium mill workers: an update. Occup Environ Med 61:57PubMedCrossRefGoogle Scholar
  44. 44.
    Ritz B (1999) Cancer mortality among workers exposed to chemicals during uranium processing. J Occup Environ Med 41:556–566PubMedCrossRefGoogle Scholar
  45. 45.
    Ritz B (1999) Radiation exposure and cancer mortality in uranium processing workers. Epidemiology 10:531–538PubMedCrossRefGoogle Scholar
  46. 46.
    Ritz B, Morgenstern H, Crawford-Brown D, Young B (2000) The effects of internal radiation exposure on cancer mortality in nuclear workers at Rocketdyne/Atomics International. Environ Health Perspect 108:743–751PubMedCrossRefGoogle Scholar
  47. 47.
    Chan C, Hughes TS, Muldoon S et al (2010) Mortality patterns among Paducah Gaseous Diffusion Plant workers. J Occup Environ Med 52:725–732PubMedCrossRefGoogle Scholar
  48. 48.
    Yiin JH, Anderson JL, Daniels RD et al (2009) A nested case–control study of multiple myeloma risk and uranium exposure among workers at the Oak Ridge Gaseous Diffusion Plant. Radiat Res 171:637–645PubMedCrossRefGoogle Scholar
  49. 49.
    Lippmann M, Yeates DB, Albert RE (1980) Deposition, retention, and clearance of inhaled particles. Br J Ind Med 37:337–362PubMedGoogle Scholar
  50. 50.
    Oberdorster G, Ferin J, Lehnert BE (1994) Correlation between particle size, in vivo particle persistence, and lung injury. Environ Health Perspect 102(Suppl 5):173–179PubMedCrossRefGoogle Scholar
  51. 51.
    Bailey MR, Ansoborlo E, Guilmette RA, Paquet F (2007) Updating the ICRP human respiratory tract model. Radiat Prot Dosim 127:31–34CrossRefGoogle Scholar
  52. 52.
    Lang S, Servomaa K, Kosma VM, Rytomaa T (1995) Biokinetics of nuclear fuel compounds and biological effects of nonuniform radiation. Environ Health Perspect 103:920–934PubMedCrossRefGoogle Scholar
  53. 53.
    Batchelor AL, Jenner TJ, Papworth DG (1982) Influence of macrophages on microdistribution of inhaled UO2 aerosol in rat lung. Phys Med Biol 27:949–957PubMedCrossRefGoogle Scholar
  54. 54.
    Henge-Napoli MH, Ansoborlo E, Claraz M, Berry JP, Cheynet MC (1996) Role of alveolar macrophages in the dissolution of two different industrial uranium oxides. Cell Mol Biol (Noisy-le-grand) 42:413–420Google Scholar
  55. 55.
    Muller HL, Taya A, Drosselmeyer E et al (1989) Cellular aspects of retention and transport of inhaled soluble and insoluble actinide compounds in the rat lung. Sci Total Environ 83:239–251PubMedCrossRefGoogle Scholar
  56. 56.
    Leach LJ, Maynard EA, Hodge HC et al (1970) A five-year inhalation study with natural uranium dioxide (UO 2) dust. I. Retention and biologic effect in the monkey, dog and rat. Health Phys 18:599–612PubMedCrossRefGoogle Scholar
  57. 57.
    Leach LJ, Yuile CL, Hodge HC (1973) A five year inhalation study with natural uranium dioxide (UO2) dust. II. Postexposure retention and biologic effects in the monkey, dog and rat. Health Phys 25:239–258PubMedCrossRefGoogle Scholar
  58. 58.
    Lataillade G, Verry M, Rateau G, Metivier H, Masse R (1995) Translocation of plutonium from rat and monkey lung after inhalation of industrial plutonium oxide and mixed uranium and plutonium oxide. Int J Radiat Biol 67:373–380PubMedCrossRefGoogle Scholar
  59. 59.
    Guilmette RA, Muggenburg BA, Hahn FF (1987) Dosimetry of 239Pu in dogs that inhaled monodisperse aerosols of 239PuO2. Radiat Res 110:199–218PubMedCrossRefGoogle Scholar
  60. 60.
    Morris KJ, Barker CL, Batchelor AL, Khanna P (1992) Dosimetric implications of pulmonary macrophage clusters observed within lungs of rats that have inhaled enriched UO2 particles. Environ Health Perspect 97:201–208PubMedGoogle Scholar
  61. 61.
    Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U (2000) Williams Hematology, 6th edn. McGraw-Hill Professional, New YorkGoogle Scholar
  62. 62.
    Thorbecke GJ, Amin AR, Tsiagbe VK (1994) Biology of germinal centers in lymphoid tissue. Faseb J 8:832–840PubMedGoogle Scholar
  63. 63.
    Griffiths NM, Van der Meeren A, Fritsch P, Abram MC, Bernaudin JF, Poncy JL (2010) Late-occurring pulmonary pathologies following inhalation of mixed oxide (uranium + plutonium oxide) aerosol in the rat. Health Phys 99:347–356PubMedCrossRefGoogle Scholar
  64. 64.
    Van der Meeren A, Gremy O (2010) Isotopic and elemental composition of plutonium/americium oxides influence pulmonary and extra-pulmonary distribution after inhalation in rats. Health Phys 99:380–387PubMedCrossRefGoogle Scholar
  65. 65.
    Veremeyeva G, Akushevich I, Pochukhailova T et al (2010) Long-term cellular effects in humans chronically exposed to ionizing radiation. Health Phys 99:337–346PubMedCrossRefGoogle Scholar
  66. 66.
    Quantification of cancer and non-cancer risks associated with multiple chronic radiation exposures: epidemiological studies, organ dose calculation and risk assessment. Final scientific report in the Frame of the European project “Alpha Risk” no 516483, period 2005–2009. European Commission 2009Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2011

Authors and Affiliations

  • I. Guseva Canu
    • 1
  • S. Jacob
    • 1
  • E. Cardis
    • 2
  • P. Wild
    • 3
  • S. Caër
    • 1
  • B. Auriol
    • 4
  • J. P. Garsi
    • 1
  • M. Tirmarche
    • 1
  • D. Laurier
    • 1
  1. 1.Institut de Radioprotection et de Sûreté Nucléaire, Service de Radiobiologie et d’EpidémiologieFontenay aux RosesFrance
  2. 2.Center for Research in Environmental Epidemiology, Barcelona Biomedical Research ParkBarcelonaSpain
  3. 3.Institut National de Recherche et de Sécurité, Service Epidémiologie des EntreprisesNancyFrance
  4. 4.Etablissement AREVA NC de Pierrelatte, Service Santé au TravailPierrelatteFrance

Personalised recommendations